Update
We provide regular updates on our latest activities, research, and development.
GN Corporation hosted a Morning seminar on Neu REFIX at the AOMC-JMS 2024 conference at Nara, Japan
Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.
Thoothukudi Medical College Dermatologists unravel a novel solution for Psoriasis Vulgaris using Neu-REFIX Beta glucan jointly with Japanese scientists.
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm…
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at MENA Rare Diseases Conference in UAE
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
Discovery of a safe adjuvant to Duchenne Muscular Dystrophy – A journey of 14 years of passion, pursuits & perseverance.
A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a…
Skeletal Muscle Fibrosis in MDX mice model of Duchenne Muscular Dystrophy ameliorated by Neu-REFIX
Published in Scientific Reports, a nature portfolio journal 15 November 2023 Significant reduction o…
Edogawa NICHE Prize lecture by Dr. John Craig Venter, geneticist and a pioneer in human genome research in Toronto
Edogawa NICHE Prize 2020 lecture by Dr. John Craig Venter, geneticist and a pioneer in human genome research in Toronto
Edogawa NICHE Prize awardee Dr John Craig Venter to deliver the lecture in UHN Ajmera Transplant Center in University of Toronto
Dr John Craig Venter to deliver the lecture in UHN Ajmera Transplant Center in University of Toronto